Ingevity Q1 2024 Adj EPS $0.52 Beats $0.32 Estimate, Sales $340.100M Beat $318.960M Estimate

5/1/24 5:33:12 PM ET

Major Chemicals

Industrials

Get the next $NGVT alert in real time by email

Ingevity (NYSE:NGVT) reported quarterly earnings of $0.52 per share which beat the analyst consensus estimate of $0.32 by 62.5 percent. This is a 52.29 percent decrease over earnings of $1.09 per share from the same period last year. The company reported quarterly sales of $340.100 million which beat the analyst consensus estimate of $318.960 million by 6.63 percent. This is a 13.37 percent decrease over sales of $392.600 million the same period last year.

Get the next $NGVT alert in real time by email

Chat with this insight

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$NGVT

Date	Price Target	Rating	Analyst
8/7/2024	$58.00	Market Perform → Market Outperform	CJS Securities
4/22/2024	$52.00 → $62.00	Hold → Buy	Jefferies
11/6/2023	$49.00	Market Outperform → Market Perform	CJS Securities
10/3/2023	$62.00 → $53.00	Buy → Hold	Loop Capital
8/7/2023	$71.00 → $60.00	Outperform → Market Perform	BMO Capital Markets
7/27/2023	$64.00 → $75.00	Hold → Buy	Loop Capital
5/5/2023	$92.00 → $64.00	Buy → Hold	Loop Capital
2/2/2023	$81.00 → $100.00	Hold → Buy	Loop Capital

More analyst ratings

$NGVT
Press Releases

Fastest customizable press release news feed in the world

Ingevity reports third quarter 2024 financial results
HIGHLIGHTS: Net sales of $376.9 million, down 16% compared to prior year, primarily due to repositioning actions in Performance Chemicals Net loss of $107.2 million and diluted loss per share of $2.95 reflects before-tax restructuring charges of $86.9 million and contract termination fees of $100.0 million; adjusted earnings of $40.2 million and diluted adjusted earnings per share (EPS) of $1.10 Adjusted EBITDA of $106.4 million and adjusted EBITDA margin of 28.2% Operating cash flow of $46.5 million with free cash flow of $28.5 million Affirms full year guidance of sales between $1.40 billion and $1.50 billion and adjusted EBITDA between $350 million and $360 million The result
10/29/24 4:15:00 PM ET
$NGVT
Major Chemicals
Industrials
Ingevity updates third-quarter 2024 earnings release and webcast dates
Ingevity Corporation (NYSE:NGVT) announced today that it will release its third-quarter 2024 earnings after the stock market close on Tuesday, October 29, 2024. The company will host a live webcast on Wednesday, October 30, at 10:00 a.m. (Eastern) to discuss third-quarter 2024 fiscal results. The webcast can be accessed here or on the investors section of Ingevity's website. You may also listen to the conference call by dialing 833 470 1428 (inside the U.S.) and entering access code 381718. Callers outside the U.S. can find global dial-in numbers here. For those unable to join the live event, a recording will be available beginning at approximately 2:00 p.m. (Eastern) on October 30, 2024,
10/16/24 9:15:00 AM ET
$NGVT
Major Chemicals
Industrials
Ingevity announces CEO transition as Fortson departs company; Fernandez-Moreno appointed as interim president and CEO
Ingevity Corporation (NYSE:NGVT) today announced that John Fortson has departed as president and chief executive officer and from the board of directors of the company, effective as of October 2, 2024. The board of directors has appointed current board director, Luis Fernandez-Moreno as interim president and chief executive officer while it conducts a search for a permanent replacement. "On behalf of the entire board, I want to thank John for his leadership and dedication to Ingevity over the past nine years," said Jean Blackwell, chair of the board of directors. "Under John's guidance, Ingevity successfully transitioned into a standalone public company, expanded its global footprint and e
10/3/24 6:15:00 AM ET
$NGVT
Major Chemicals
Industrials

$NGVT
Financials

Live finance-specific insights

Ingevity reports third quarter 2024 financial results
HIGHLIGHTS: Net sales of $376.9 million, down 16% compared to prior year, primarily due to repositioning actions in Performance Chemicals Net loss of $107.2 million and diluted loss per share of $2.95 reflects before-tax restructuring charges of $86.9 million and contract termination fees of $100.0 million; adjusted earnings of $40.2 million and diluted adjusted earnings per share (EPS) of $1.10 Adjusted EBITDA of $106.4 million and adjusted EBITDA margin of 28.2% Operating cash flow of $46.5 million with free cash flow of $28.5 million Affirms full year guidance of sales between $1.40 billion and $1.50 billion and adjusted EBITDA between $350 million and $360 million The result
10/29/24 4:15:00 PM ET
$NGVT
Major Chemicals
Industrials
Ingevity updates third-quarter 2024 earnings release and webcast dates
Ingevity Corporation (NYSE:NGVT) announced today that it will release its third-quarter 2024 earnings after the stock market close on Tuesday, October 29, 2024. The company will host a live webcast on Wednesday, October 30, at 10:00 a.m. (Eastern) to discuss third-quarter 2024 fiscal results. The webcast can be accessed here or on the investors section of Ingevity's website. You may also listen to the conference call by dialing 833 470 1428 (inside the U.S.) and entering access code 381718. Callers outside the U.S. can find global dial-in numbers here. For those unable to join the live event, a recording will be available beginning at approximately 2:00 p.m. (Eastern) on October 30, 2024,
10/16/24 9:15:00 AM ET
$NGVT
Major Chemicals
Industrials
Ingevity announces additional steps to advance strategic repositioning and improve profitability of its Performance Chemicals segment
Will optimize existing manufacturing footprint by consolidating oleo-based chemical refining with existing crude tall oil refining at the company's North Charleston, South Carolina, facility, and closing its Crossett, Arkansas, facility in August Manufacturing consolidation will result in approximately $20 million to $25 million in annual savings beginning in 2025 Executes corporate and business-related cost reduction actions resulting in additional annual savings of approximately $10 million beginning in 2025 Expects charges associated with these actions of approximately $100 million, with approximately $65 million to be non-cash Continues to evaluate the Performance Chemicals
7/31/24 4:15:00 PM ET
$NGVT
Major Chemicals
Industrials

Ingevity announces CEO transition as Fortson departs company; Fernandez-Moreno appointed as interim president and CEO
Ingevity Corporation (NYSE:NGVT) today announced that John Fortson has departed as president and chief executive officer and from the board of directors of the company, effective as of October 2, 2024. The board of directors has appointed current board director, Luis Fernandez-Moreno as interim president and chief executive officer while it conducts a search for a permanent replacement. "On behalf of the entire board, I want to thank John for his leadership and dedication to Ingevity over the past nine years," said Jean Blackwell, chair of the board of directors. "Under John's guidance, Ingevity successfully transitioned into a standalone public company, expanded its global footprint and e
10/3/24 6:15:00 AM ET
$NGVT
Major Chemicals
Industrials
Ingevity names new general counsel and chief human resources officer to executive leadership team
Ingevity Corporation (NYSE:NGVT) today announced the appointment of Ryan C. Fisher as senior vice president, general counsel and secretary and Terry Dyer as senior vice president and chief human resources officer. "We are excited to add Ryan and Terry to our executive leadership team," said Ingevity president and CEO, John Fortson. "Both leaders bring extensive experience, with successful track records of leading companies through business growth and expansion. I am confident that their contributions will be instrumental in driving our continued success and innovation." Fisher has held various leadership positions during his 18-year tenure with Ingevity and its predecessors. Most recent
7/17/24 4:15:00 PM ET
$NGVT
Major Chemicals
Industrials
Allegion Appoints Stacy Cozad as New General Counsel
Allegion plc (NYSE:ALLE), a leading global security products and solutions provider, has appointed Stacy Cozad as senior vice president, general counsel and corporate secretary, effective Aug. 5, 2024. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240701071652/en/Stacy Cozad (Photo: Business Wire) In this role, Cozad will have responsibility for Allegion's global legal affairs, trade compliance, enterprise risk management and corporate communications functions. She will succeed Jeff Braun, who has announced plans to retire on Dec. 31, 2024, and will serve as an advisor during the transition. Cozad has nearly 30 years of exper
7/1/24 8:00:00 AM ET
$ALLE
$NGVT
$SPR
Diversified Commercial Services
Consumer Discretionary
Major Chemicals
Industrials

Ingevity Q1 2024 Adj EPS $0.52 Beats $0.32 Estimate, Sales $340.100M Beat $318.960M Estimate

Chat with this insight

Recent Analyst Ratings for $NGVT

$NGVT Analyst Ratings

Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

Ingevity upgraded by CJS Securities with a new price target

Ingevity upgraded by Jefferies with a new price target

Ingevity downgraded by CJS Securities with a new price target

$NGVT Press Releases

Fastest customizable press release news feed in the world

Ingevity reports third quarter 2024 financial results

Ingevity updates third-quarter 2024 earnings release and webcast dates

Ingevity announces CEO transition as Fortson departs company; Fernandez-Moreno appointed as interim president and CEO

$NGVT Financials

Live finance-specific insights

Ingevity reports third quarter 2024 financial results

Ingevity updates third-quarter 2024 earnings release and webcast dates

Ingevity announces additional steps to advance strategic repositioning and improve profitability of its Performance Chemicals segment

$NGVT Leadership Updates

Live Leadership Updates

$NGVT Large Ownership Changes

This live feed shows all institutional transactions in real time.

Ingevity announces CEO transition as Fortson departs company; Fernandez-Moreno appointed as interim president and CEO

Ingevity names new general counsel and chief human resources officer to executive leadership team

Allegion Appoints Stacy Cozad as New General Counsel

Amendment: SEC Form SC 13G/A filed by Ingevity Corporation

Amendment: SEC Form SC 13G/A filed by Ingevity Corporation

SEC Form SC 13D/A filed by Ingevity Corporation (Amendment)

$NGVT Market Insights

Live Market Insights

Assessing Ingevity: Insights From 5 Financial Analysts

Wells Fargo Maintains Equal-Weight on Ingevity, Lowers Price Target to $45

Ingevity And Ultrapolymers Group Partner For European Sales Of Capa Caprolactone Bioplastics

$NGVT SEC Filings

SEC Form 10-Q filed by Ingevity Corporation

Ingevity Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

Ingevity Corporation filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits

$NGVT Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

Interim President & CEO Fernandez-Moreno Luis M was granted 26,696 shares, increasing direct ownership by 119% to 49,048 units (SEC Form 4)

SEC Form 3 filed by new insider Dyer Terrance M

SVP, Finance Platt Phillip John was granted 11,233 shares, increasing direct ownership by 68% to 27,659 units (SEC Form 4)

Recent Analyst Ratings for
$NGVT

$NGVT
Analyst Ratings

$NGVT
Press Releases

$NGVT
Financials

$NGVT
Leadership Updates

$NGVT
Large Ownership Changes

$NGVT
Market Insights

$NGVT
SEC Filings

$NGVT
Insider Trading